Ishida S - Search Results

1

[Myelofibrosis ameliorated after treatment for nontuberculous mycobacterial infection].

Saito T, Hattori K, Yamashita T, Ueda M, Okada K, Ishida S, Sakai T, Kasahara I, Isogai S, Kumagai T. Saito T, et al. Among authors: ishida s. Rinsho Ketsueki. 2015 Jan;56(1):25-9. doi: 10.11406/rinketsu.56.25. Rinsho Ketsueki. 2015. PMID: 25745964 Review. Japanese.

2

[Late-onset refractory autoimmune hemolytic anemia following autologous hematologic recovery after allo-HSCT in aplastic anemia-PNH syndrome].

Kishida Y, Shingai N, Nakao S, Ishida S, Yamamoto K, Kurosawa S, Hino Y, Hattori K, Senoo Y, Yoshioka K, Toya T, Najima Y, Kobayashi T, Sakamaki H, Ohashi K, Doki N. Kishida Y, et al. Among authors: ishida s. Rinsho Ketsueki. 2022;63(5):347-352. doi: 10.11406/rinketsu.63.347. Rinsho Ketsueki. 2022. PMID: 35662156 Japanese.

3

FLT3-ITD induces expression of Pim kinases through STAT5 to confer resistance to the PI3K/Akt pathway inhibitors on leukemic cells by enhancing the mTORC1/Mcl-1 pathway.

Okada K, Nogami A, Ishida S, Akiyama H, Chen C, Umezawa Y, Miura O. Okada K, et al. Among authors: ishida s. Oncotarget. 2017 Dec 4;9(10):8870-8886. doi: 10.18632/oncotarget.22926. eCollection 2018 Feb 6. Oncotarget. 2017. PMID: 29507660 Free PMC article.

4

Molecular mechanisms for enhancement of stromal cell-derived factor 1-induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1).

Umezawa Y, Akiyama H, Okada K, Ishida S, Nogami A, Oshikawa G, Kurosu T, Miura O. Umezawa Y, et al. Among authors: ishida s. J Biol Chem. 2017 Dec 1;292(48):19639-19655. doi: 10.1074/jbc.M117.779603. Epub 2017 Oct 3. J Biol Chem. 2017. PMID: 28974577 Free PMC article.

5

Mechanisms for mTORC1 activation and synergistic induction of apoptosis by ruxolitinib and BH3 mimetics or autophagy inhibitors in JAK2-V617F-expressing leukemic cells including newly established PVTL-2.

Ishida S, Akiyama H, Umezawa Y, Okada K, Nogami A, Oshikawa G, Nagao T, Miura O. Ishida S, et al. Oncotarget. 2018 Jun 1;9(42):26834-26851. doi: 10.18632/oncotarget.25515. eCollection 2018 Jun 1. Oncotarget. 2018. PMID: 29928488 Free PMC article.

6

Inhibition of the STAT5/Pim Kinase Axis Enhances Cytotoxic Effects of Proteasome Inhibitors on FLT3-ITD-Positive AML Cells by Cooperatively Inhibiting the mTORC1/4EBP1/S6K/Mcl-1 Pathway.

Nogami A, Okada K, Ishida S, Akiyama H, Umezawa Y, Miura O. Nogami A, et al. Among authors: ishida s. Transl Oncol. 2019 Feb;12(2):336-349. doi: 10.1016/j.tranon.2018.11.001. Epub 2018 Nov 22. Transl Oncol. 2019. PMID: 30472492 Free PMC article.

7

Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress.

Akiyama H, Umezawa Y, Ishida S, Okada K, Nogami A, Miura O. Akiyama H, et al. Among authors: ishida s. Cancer Lett. 2019 Jul 1;453:84-94. doi: 10.1016/j.canlet.2019.03.046. Epub 2019 Apr 1. Cancer Lett. 2019. PMID: 30946869

8

Inhibition of USP9X Downregulates JAK2-V617F and Induces Apoptosis Synergistically with BH3 Mimetics Preferentially in Ruxolitinib-Persistent JAK2-V617F-Positive Leukemic Cells.

Akiyama H, Umezawa Y, Watanabe D, Okada K, Ishida S, Nogami A, Miura O. Akiyama H, et al. Among authors: ishida s. Cancers (Basel). 2020 Feb 10;12(2):406. doi: 10.3390/cancers12020406. Cancers (Basel). 2020. PMID: 32050632 Free PMC article.

9

Toxic encephalopathy after exposure to azacitidine.

Watanabe K, Doki N, Miura Y, Hagino T, Kurosawa S, Hino Y, Shingai N, Yoshioka K, Ishida S, Igarashi A, Najima Y, Kobayashi T, Kakihana K, Sakamaki H, Ohashi K. Watanabe K, et al. Among authors: ishida s. Leuk Lymphoma. 2015 May;56(5):1538-9. doi: 10.3109/10428194.2014.964701. Epub 2014 Nov 5. Leuk Lymphoma. 2015. PMID: 25224457 No abstract available.

10

Clinical impact of CD25 expression on outcomes of allogeneic hematopoietic stem cell transplant for cytogenetically intermediate-risk acute myeloid leukemia.

Ikegawa S, Doki N, Yamamoto K, Shingai N, Takahashi Y, Aoki J, Yoshioka K, Narukawa K, Ishida S, Igarashi A, Oshikawa G, Kobayashi T, Kakihana K, Sakamaki H, Haraguchi K, Okuyama Y, Ohashi K. Ikegawa S, et al. Among authors: ishida s. Leuk Lymphoma. 2015 Jun;56(6):1874-7. doi: 10.3109/10428194.2014.974044. Epub 2014 Nov 14. Leuk Lymphoma. 2015. PMID: 25311493 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,588 results

Search Page